… genital warts over 4, 8, 12 or 16 weeks. A total of 120 women with a history of genital warts
for a … thrice weekly for women with external genital warts may provide a reasonable approach …

… genital warts, including three with giant ano-genital warts (Buschke Löwenstein tumour), were
included in this open-label pilot study… label pilot study for the treatment of ano-genital warts…

… Within this study, none of the patients with genital warts had syphilis, active hepatitis B,
active hepatitis C or HIV infection. Moreover, the frequency of positive serum HSV1IgG levels …

… There are more than 70 genotypes of HPV, and the genotypes are referenced by numbers.
The common wart is most frequently caused by genotypes HPV-1, 2, 4, 27 and 57. Warts are …

… study confirms the findings in a previous open-label trial that … label phase ii pilot study
investigating the optimal duration of imiquimod 5% cream for the treatment of external genital warts …

… We conducted an open-label uncontrolled pilot clinical study … Genital warts had been
described at least as far back as 400 … However, following the promising results of this pilot trial, we …

… An open-label phase II pilot study investigating the optimal duration of imiquimod 5%
cream for the treatment of external genital warts in women. Int J STD AIDS. 2006;17:448-452. …

… About 90% of genital warts are caused by human papillomavirus (HPV) types 6 or 11, and
half of episodes diagnosed are recurrences. The best and most cost-effective treatment for …

… A small, open-label study of 5- fluorouracil found that 26 of 46 patients (56.5%) had complete
or partial response, but 25% recurred at 6 months [57]. A prospective pilot study of infrared …

… that called anogenital warts (AGW) (genital warts, condyloma acuminate, condylomas) (2,3)
(Figures 1-3). There are more than 200 hundred variants of HPV (4). HPV is divided into two …